Prognostic factors in prostate cancer.
The ability of traditional and newer molecular-based prognostic factors to predict the outcome of prostate cancer is of considerable interest to urologists, pathologists, and patients. In this review, a series of traditional and newer molecular-based prognostic factors are considered, including those that have achieved widespread use, newer tests that are beginning to be used in clinical practice, and emerging molecular markers that have yet to be widely validated in the published literature or clinical trials.
Department of Pathology and Laboratory Medicine, Albany Medical College, NY 12208, USA.
Jeffrey S
JS
Ross
Timothy A
TA
Jennings
Tipu
T
Nazeer
Christine E
CE
Sheehan
Hugh A G
HA
Fisher
Ronald A
RA
Kauffman
Shagul
S
Anwar
Bhaskar V S
BV
Kallakury
D002455:Cell Division; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000032:analysis; D016147:Genes, Tumor Suppressor; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009857:Oncogenes; D011003:Ploidies; D011471:Prostatic Neoplasms / Q000098:blood supply / Q000235:genetics / Q000473:pathology*; D011944:Receptors, Androgen / Q000032:analysis
D004273:DNA, Neoplasm; D011944:Receptors, Androgen